Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **prokaryotic small ribosomal subunit** (30S subunit) is a large ribonucleoprotein complex unique to bacteria and archaea, composed of a single molecule of 16S rRNA and 21 ribosomal proteins. This subunit plays a central role in the translation of genetic information by providing the mRNA binding site, ensuring correct codon-anticodon pairing during decoding, and initiating protein synthesis in cooperation with translation factors and the 50S subunit. The 30S subunit is the molecular target for many clinically important antibiotics including aminoglycosides and tetracyclines, which act by interfering with decoding accuracy or translocation, ultimately inhibiting bacterial growth. The high degree of evolutionary conservation in its rRNA makes the subunit's 16S rRNA a gold standard for bacterial identification and phylogenetics. Because of its essential role in protein synthesis and its unique structure compared to eukaryotic cytoplasmic ribosomes, it is an important and validated antibacterial drug target, although risks of toxicity and resistance persist with 30S-targeting agents.
Inhibition of translation by binding to functional sites on the 30S subunit (decoding or tRNA interaction regions); Misreading of genetic code (e.g., aminoglycosides like streptomycin induce errors during translation); Blockade of translocation and chain elongation (e.g., spectinomycin)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prokaryotic small ribosomal subunit (30S subunit) (30S subunit).